First Time Loading...

Guardion Health Sciences Inc
NASDAQ:GHSI

Watchlist Manager
Guardion Health Sciences Inc Logo
Guardion Health Sciences Inc
NASDAQ:GHSI
Watchlist
Price: 8.92 USD 9.85% Market Closed
Updated: Mar 19, 2024

Intrinsic Value

GHSI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provid... [ Read More ]

The intrinsic value of one GHSI stock under the Base Case scenario is 6.07 USD. Compared to the current market price of 8.92 USD, Guardion Health Sciences Inc is Overvalued by 32%.

Key Points:
GHSI Intrinsic Value
Base Case
6.07 USD
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Guardion Health Sciences Inc

Backtest GHSI Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GHSI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
Guardion Health Sciences Inc

Current Assets 12.8m
Cash & Short-Term Investments 7.7m
Receivables 1.8m
Other Current Assets 3.4m
Non-Current Assets 40k
PP&E 40k
Current Liabilities 1.4m
Accounts Payable 880k
Accrued Liabilities 550k
Non-Current Liabilities 3.8m
Other Non-Current Liabilities 3.8m
Efficiency

Earnings Waterfall
Guardion Health Sciences Inc

Revenue
12.1m USD
Cost of Revenue
-7.1m USD
Gross Profit
5m USD
Operating Expenses
-9.5m USD
Operating Income
-4.5m USD
Other Expenses
-5.6m USD
Net Income
-10.1m USD

Free Cash Flow Analysis
Guardion Health Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

GHSI Profitability Score
Profitability Due Diligence

Guardion Health Sciences Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
ROIC is Increasing
32/100
Profitability
Score

Guardion Health Sciences Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

GHSI Solvency Score
Solvency Due Diligence

Guardion Health Sciences Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
57/100
Solvency
Score

Guardion Health Sciences Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GHSI Price Targets Summary
Guardion Health Sciences Inc

Wall Street analysts forecast GHSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GHSI is 40.8 USD with a low forecast of 40.4 USD and a high forecast of 42 USD.

Lowest
Price Target
40.4 USD
353% Upside
Average
Price Target
40.8 USD
357% Upside
Highest
Price Target
42 USD
371% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

GHSI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

GHSI Price
Guardion Health Sciences Inc

1M 1M
+6%
6M 6M
+16%
1Y 1Y
+91%
3Y 3Y
-93%
5Y 5Y
-99%
10Y 10Y
-99%
Annual Price Range
8.92
52w Low
4.66
52w High
8.92
Price Metrics
Average Annual Return -36.53%
Standard Deviation of Annual Returns 93.59%
Max Drawdown -100%
Shares Statistics
Market Capitalization 11.4m USD
Shares Outstanding 1 275 240
Percentage of Shares Shorted 12.63%

GHSI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Guardion Health Sciences Inc Logo
Guardion Health Sciences Inc

Country

United States of America

Industry

Consumer products

Market Cap

11.4m USD

Dividend Yield

0%

Description

Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products and devices designed to support healthcare professionals and providers, and their patients and consumers. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplement chews for bone health, immune health, and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel-flavored calcium chews constitute the main product category. The company also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The firm's GlaucoCetin, a medical food, which offers a formula that is designed to support proper mitochondrial function in the optic nerve cells in glaucoma patients.

Contact

TEXAS
Houston
2925 Richmond Avenue, Suite 1200
+18008735141.0
http://guardionhealth.com/

IPO

2019-04-05

Employees

13

Officers

Independent Chairman & Secretary
Mr. Robert Neal Weingarten
Chief Commercial Officer
Mr. Craig J. Sheehan
President & CEO
Ms. Janet Hall
Chief Accounting Officer
Ms. Katie Cox

See Also

Discover More
What is the Intrinsic Value of one GHSI stock?

The intrinsic value of one GHSI stock under the Base Case scenario is 6.07 USD.

Is GHSI stock undervalued or overvalued?

Compared to the current market price of 8.92 USD, Guardion Health Sciences Inc is Overvalued by 32%.